VAERS Reports UT8134LA

VAERS 2688873

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8134LA

schwer

Staat: WI
Alter: 11,0
Geschlecht: M
Eingang: 29.09.2023
Impfdatum: 28.09.2023
Beginn: 29.09.2023
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood glucose Hyperhidrosis Joint injury Pallor Syncope Xanthopsia

Symptomtext

The following day after giving vaccine, child was at school running from building to building on playground equipment. At end of recess when heading in for lunch, he hit knee hard against a piece of equipment. When he was about to go into the school, his vision turned yellow, became pale and very sweaty then fainted. Teacher was able to catch him. EMS and parent called, Evaluated at school. Mother called and reported incident to clinic at 2:10 pm. She requested incident be reported to VAERS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: HR, BP, and BS checked when evaluated at school.
Aktuelle Erkrankungen: none known , but does have 3-MCC deficiency.
Vorgeschichte: 3-MCC deficiency
Andere Medikamente: unknown
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2686816

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8134LA

gering

Staat: NY
Alter: 72,0
Geschlecht: F
Eingang: 26.09.2023
Impfdatum: 19.09.2023
Beginn: 19.09.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered No adverse event Wrong product administered

Symptomtext

administering fluzone quadrivalent to a 72-year-old patient instead of fluzone high dose quadrivalent with no reported adverse event; administering fluzone quadrivalent at a dose of 0.25 ml with no reported adverse event; Initial information received on 20-Sep-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 72-years-old female patient who was administered influenza quadrival A-B vaccine [Fluzone Quadrivalent] instead of influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent] at a dose of 0.25 ml with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant(s): No other vaccines. On 19-Sep-2023, the patient received 0.25 mL dose of suspect influenza quadrival A-B vaccine, Suspension for injection (Frequency: once; Strength: standard) (batch number: UT8134LA; expiry date: 30-Jun-2024) instead of influenza quadrival A-B high dose HV vaccine (batch number; expiry date: unknown) via intramuscular route in unknown administration site for Immunization with no reported adverse event (wrong product administered) (incorrect dose administered) (same day latency). Action taken: not applicable. At time of reporting, the outcome was Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -